These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies. Rivière P; Vermeire S; Irles-Depe M; Van Assche G; Rutgeerts P; Denost Q; Wolthuis A; D'Hoore A; Laharie D; Ferrante M Clin Gastroenterol Hepatol; 2021 Apr; 19(4):713-720.e1. PubMed ID: 32272248 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease. Bak MTJ; Ten Bokkel Huinink S; Erler NS; Bodelier AGL; Dijkstra G; Romberg-Camps M; de Boer NKH; Hoentjen F; Stassen LPS; van der Meulen-de Jong AE; West RL; van Ruler O; van der Woude CJ; de Vries AC; Am J Gastroenterol; 2024 Feb; 119(2):306-312. PubMed ID: 37737675 [TBL] [Abstract][Full Text] [Related]
8. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease. Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500 [TBL] [Abstract][Full Text] [Related]
9. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn's Disease. Shah RS; Bachour S; Joseph A; Xiao H; Lyu R; Syed H; Li T; Pothula S; Vinaithirthan V; Ali AH; Contreras S; Hu JH; Barnes EL; Axelrad JE; Holubar SD; Regueiro M; Cohen BL; Click BH Clin Gastroenterol Hepatol; 2024 Apr; 22(4):847-857.e12. PubMed ID: 37879523 [TBL] [Abstract][Full Text] [Related]
11. Histologic Activity from Neoterminal Ileal Biopsies in Patients with Crohn's Disease in Endoscopic Remission is Associated with Postoperative Recurrence. Shah RS; Hu JH; Bachour S; Joseph A; Syed H; Yang Q; Ali AH; Li T; Contreras S; Pothula S; Vinaithirthan V; Regueiro M; Axelrad J; Barnes EL; Cohen BL; Click BH Am J Gastroenterol; 2024 Jul; ():. PubMed ID: 39007494 [TBL] [Abstract][Full Text] [Related]
12. American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn's Disease Post-ileocolic Resection. Li T; Shah R; Click B; Cohen BL; Barnes E; Joseph A; Bachour S; Hu J; Contreras S; Li E; Axelrad J Crohns Colitis 360; 2024 Jan; 6(1):otae016. PubMed ID: 38525200 [TBL] [Abstract][Full Text] [Related]
13. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. Aguas M; Bastida G; Cerrillo E; Beltrán B; Iborra M; Sánchez-Montes C; Muñoz F; Barrio J; Riestra S; Nos P World J Gastroenterol; 2012 Aug; 18(32):4391-8. PubMed ID: 22969204 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease. Yang E; Panaccione N; Whitmire N; Dulai PS; Vande Casteele N; Singh S; Boland BS; Collins A; Sandborn WJ; Panaccione R; Battat R Aliment Pharmacol Ther; 2020 Jun; 51(11):1031-1038. PubMed ID: 32329532 [TBL] [Abstract][Full Text] [Related]
16. Top-down Versus Step-up Strategies to Prevent Postoperative Recurrence in Crohn's Disease. Buisson A; Blanco L; Manlay L; Reymond M; Dapoigny M; Rouquette O; Dubois A; Pereira B Inflamm Bowel Dis; 2023 Feb; 29(2):185-194. PubMed ID: 35389489 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study. Yanai H; Kagramanova A; Knyazev O; Sabino J; Haenen S; Mantzaris GJ; Mountaki K; Armuzzi A; Pugliese D; Furfaro F; Fiorino G; Drobne D; Kurent T; Yassin S; Maharshak N; Castiglione F; de Sire R; Nardone OM; Farkas K; Molnar T; Krznaric Z; Brinar M; Chashkova E; Livne Margolin M; Kopylov U; Bezzio C; Bar-Gil Shitrit A; Lukas M; Chaparro M; Truyens M; Nancey S; Lobaton T; Gisbert JP; Saibeni S; Bacsúr P; Bossuyt P; Schulberg J; Hoentjen F; Viganò C; Palermo A; Torres J; Revés J; Karmiris K; Velegraki M; Savarino E; Markopoulos P; Tsironi E; Ellul P; Calviño Suárez C; Weisshof R; Ben-Hur D; Naftali T; Eriksson C; Koutroubakis IE; Foteinogiannopoulou K; Limdi JK; Liu E; Surís G; Calabrese E; Zorzi F; Filip R; Ribaldone DG; Snir Y; Goren I; Banai-Eran H; Broytman Y; Amir Barak H; Avni-Biron I; Ollech JE; Dotan I; Aharoni Golan M J Crohns Colitis; 2022 Dec; 16(12):1882-1892. PubMed ID: 35895074 [TBL] [Abstract][Full Text] [Related]
18. The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn's disease: A 5-year prospective cohort study. Yamamoto T; Bamba T; Umegae S; Matsumoto K United European Gastroenterol J; 2013 Aug; 1(4):294-8. PubMed ID: 24917974 [TBL] [Abstract][Full Text] [Related]
19. Comparison of surgery rates in biologic-naïve patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN. Vu M; Ghosh S; Umashankar K; Weber L; Landis C; Candela N; Chastek B BMC Gastroenterol; 2023 Mar; 23(1):87. PubMed ID: 36966279 [TBL] [Abstract][Full Text] [Related]
20. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]